跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
陳 涵栩
教授
醫學系內科學科
電子郵件
chenhs
vghtpe.gov
tw
h-index
h10-index
h5-index
2084
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
487
引文
13
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
233
引文
10
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1998 …
2026
每年研究成果
概覽
指紋
網路
研究成果
(100)
類似的個人檔案
(6)
指紋
查看啟用 Harn-Shen Chen 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
95% Confidence Interval
46%
Albuminuria
14%
All-cause Mortality
17%
Ankle-brachial Index
18%
Basal Insulin Therapy
18%
Blood Glucose
15%
Breast Milk
16%
Clinical Outcomes
20%
Composite Events
13%
Diabetes
15%
Diabetic Kidney Disease
21%
Diabetic Retinopathy
14%
Estimated Glomerular Filtration Rate
15%
General Hospital
20%
Glucose Homeostasis
19%
Glycemic Control
37%
Growth Factors
21%
Growth Hormone
30%
Hazard Ratio
33%
HbA1c Levels
18%
Health-related Quality of Life
24%
Hemoglobin A1c (HbA1c)
30%
Hyperglycemia
14%
Impaired Fasting Glucose
14%
Inductively Coupled Plasma Mass Spectrometry
19%
Insulin
25%
Insulin Sensitivity
19%
Insulin-like
20%
Iodine
15%
Iodine nutrition
30%
Iodine Status
15%
Long-term Glycaemic Control
18%
Metabolic Syndrome
34%
Metabolic Syndrome Components
20%
Middle-aged Adults
21%
Newly Diagnosed
14%
Northern Taiwan
15%
Oral Glucose Tolerance Test
22%
Pre-diabetes (pre-DM)
32%
Pregnant Women
15%
Randomized Controlled Trial
14%
Renal Outcome
21%
Retinopathy
18%
Spot Urine
13%
Taipei
25%
Taiwan
62%
Taiwanese
15%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetic Patients
87%
Urinary Iodine Concentration
44%
Medicine and Dentistry
Acromegaly
43%
Albuminuria
11%
All Cause Mortality
20%
Ankle Brachial Index
24%
Blood Glucose
16%
Cardiovascular Disease
10%
Cardiovascular Risk
13%
Cardiovascular System
38%
Cell Function
19%
Cohort Analysis
17%
Creatinine
9%
Diabetes
30%
Diabetes Mellitus
50%
Diabetic Nephropathy
17%
Diabetic Retinopathy
18%
Glomerular Filtration Rate
16%
Glucagon-Like Peptide-1 Agonist
12%
Glucose
24%
Glucose Homeostasis
13%
Glycated Hemoglobin
10%
Glycemic Control
49%
Glycon
15%
Growth Hormone
24%
Hazard Ratio
40%
Hemoglobin A1c
40%
Hyperglycemia
42%
Impaired Fasting Glucose
10%
Insulin
48%
Insulin Sensitivity
11%
Insulin Treatment
33%
Iodine
36%
Maturity Onset Diabetes of the Young
94%
Metabolic Syndrome
18%
Microalbuminuria
12%
Middle Age
14%
Nutritional Status
24%
Observational Study
10%
Octreotide
12%
Oral Glucose Tolerance Test
22%
Papillary Thyroid Cancer
12%
Patient with Type 2 Diabetes
43%
Prevalence
20%
Retinopathy
21%
Sitagliptin
9%
Somatomedin C
21%
Systolic Blood Pressure
12%
Thyroid Gland
14%
Transsphenoidal Surgery
13%
Tumor Necrosis Factor Receptor 1
12%
Urinary System
19%
Nursing and Health Professions
Albumin
6%
Albuminuria
9%
All Cause Mortality
10%
Anaplastic Thyroid Carcinoma
6%
Ankle Brachial Index
6%
Atropine
6%
Bloating
7%
Blood Pressure
13%
Body Mass
7%
Cardiovascular System
8%
Chronic Kidney Failure
6%
Clinical Outcome
6%
Cognitive Defect
7%
Cohort Analysis
13%
Confidence Interval
21%
Cross-Sectional Study
6%
Diabetes Mellitus
28%
Diabetic Nephropathy
16%
Diabetic Retinopathy
9%
Economic and Social Development
9%
Education
10%
Estimated Glomerular Filtration Rate
15%
Fibroblast Growth Factor 21
6%
Fructosamine
16%
Gender Difference
6%
General Hospital
10%
Glomerulus Filtration Rate
6%
Glucose
19%
Glucose Blood Level
32%
Glycemic Control
22%
Hazard Ratio
28%
Health Survey
8%
Hemoglobin A1c
15%
Hyperglycemia
13%
Insulin
24%
Isophane Insulin
6%
Isotopes of Potassium
6%
Logistic Regression Analysis
7%
Maturity Onset Diabetes of the Young
70%
Metabolic Syndrome X
30%
Nutrition
6%
Nutritional Status
12%
Obesity
9%
Patient with Type 2 Diabetes
44%
Prospective Cohort Study
6%
Quality of Life
36%
Retinopathy
8%
Self Monitoring
15%
Tincture of Iodine
24%
Urine Sampling
8%
